The National Health Service (Pharmaceutical Services) (Wales) (Amendment) (Amendment) Regulations 2024
W.S.I. 2024/1315 · Made 10 December 2024
National Health Service, Wales
Made at 12.59 p.m. on 10 December 2024
Laid before Senedd Cymru at 5.45 p.m. on 10 December 2024
Coming into force 31 December 2024
The Welsh Ministers, in exercise of the powers conferred on them by sections 15, 80, 104 and 203(9) and (10) of the National Health Service (Wales) Act 2006f1, make the following Regulations.
Annotations to the whole text
Footnotes
- f1
Contents
- 1Title and coming into force
- 2Amendment to the National Health Service (Pharmaceutical Services) (Wales) (Amendment) Regulations 2024
- Signature
- Explanatory note
1Title and coming into force
The title of these Regulations is the National Health Service (Pharmaceutical Services) (Wales) (Amendment) (Amendment) Regulations 2024 and they come into force on 31 December 2024.
2Amendment to the National Health Service (Pharmaceutical Services) (Wales) (Amendment) Regulations 2024
In the National Health Service (Pharmaceutical Services) (Wales) (Amendment) Regulations 2024f1, for regulation 1(3) substitute—
“(3)This regulation and regulation 3(5) come into force on 1 January 2025.”
Signature
Jeremy Miles
Cabinet Secretary for Health and Social Care, one of the Welsh Ministers
At 12.59 p.m. on 10 December 2024
Explanatory note
(This note is not part of the Regulations)
These Regulations substitute a new regulation 1(3) into the National Health Service (Pharmaceutical Services) (Wales) (Amendment) Regulations 2024.
The Welsh Ministers’ Code of Practice on the carrying out of Regulatory Impact Assessments was considered in relation to these Regulations. As a result, a regulatory impact assessment has not been prepared as to the likely costs and benefits of complying with these Regulations.